NCT06135038

Brief Summary

Background: Chronic shoulder pain (CSP) is a musculoskeletal disease characterized by pain lasting more than 3 months. Purpose: This study aimed to determine whether pre-treatment injection in CSP treatment contributes to pain, functionality and quality of life. Methods: A total of 110 patients who met the inclusion criteria of the study were divided into 2 groups (55 patients in each group). A standard 15-session physical therapy program (hot pack, transcutaneous electric nerve stimulation(TENS), US and therapeutic exercises) was applied to all patients in both groups. Suprascapular Nerve Block was applied to Group I before treatment. Assessments were made using VAS-Pain, Shoulder Pain and Disability Index (SPADI) and The Nottingham Health Profile (NHP) before and at the end of the treatment and in the posttreatment 3th months.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
110

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Feb 2020

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2020

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2020

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2020

Completed
2.9 years until next milestone

First Submitted

Initial submission to the registry

November 3, 2023

Completed
15 days until next milestone

First Posted

Study publicly available on registry

November 18, 2023

Completed
Last Updated

November 18, 2023

Status Verified

November 1, 2023

Enrollment Period

3 months

First QC Date

November 3, 2023

Last Update Submit

November 11, 2023

Conditions

Keywords

chronic shoulder painshoulder injectionsuprascapular nerve blockphysiotherapy

Outcome Measures

Primary Outcomes (3)

  • Visual analogue scale (VAS)-pain

    Visual analogue scale (VAS) is one of the frequent methods used in the identification of the severity of pain. It is formed by 100 mm vertical and horizontal lines. The distance between the lowest VAS score and the mark of the patient was measured as mm (0-100) and the numerical value of the pain severity was determined .

    Outcome measure evaluated; 1. Before the intervention, 2. Immediately after the intervention, 3. At 12 weeks after the end of the intervention (approximately week 15)

  • Shoulder Pain and Disability Index (SPADI)

    The shoulder Pain and Disability Index was developed to evaluate pain and disability . It consists of 2 subscales, consisting of a total of 13 items (5 items for pain, 8 items for disability) numerically rated from 0 to 10. The total score ranges from 0 to 100. Higher scores represent increased pain and impaired shoulder function.

    Outcome measure evaluated; 1. Before the intervention, 2. Immediately after the intervention, 3. At 12 weeks after the end of the intervention (approximately week 15)

  • The Nottingham Health Profile (NHP)

    The Nottingham Health Profileis a general quality of life questionnaire measuring self-perceived health problems and the effects of these problems on normal daily activities. The questionnaire consists of 38 questions and six domains. For each domain, "0" represents the best state of health and "100" the worst state of health.

    Outcome measure evaluated; 1. Before the intervention 2. Immediately after the intervention, 3. At 12 weeks after the end of the intervention (approximately week 15)

Study Arms (2)

Suprascapular nerve block with physical therapy

ACTIVE COMPARATOR

Suprascapular Nerve Block was applied to Group I before physical therapy program. After the nerve block, a physical therapy program including standard procedure was applied to the patients in Group 1.

Other: Suprascapular nerve block with physical therapy

Only physical therapy

ACTIVE COMPARATOR

Patients in group 2 were applied only a physical therapy program that included the same standard procedure as group 1.

Other: Group 2 Physical therapy

Interventions

Suprascapular nerve block was applied to the relevant shoulder area of all patients before treatment. Afterwards, a physical therapy program (5 days a week for 3 weeks, a total of 15 sessions) was applied, including 20 minutes of hot pack at 60°C, 20 minutes of conventional TENS at 80 Hz and US at 3 MHz frequency and 1.5 watt/cm2 intensity. After physical therapy, all the participants received therapeutic exercise program (3 sets of 10 reps with 3- minute intervals between the sets) consisting of active-assisted ROM, passive stretching and Codman exercises for their shoulder joint for 30 minutes in accompany with a physiotherapist.

Also known as: Transcutaneous Electrical Nerve Stimulation (TENS), Hot Pack, Ultrasound(US) Therapy, Therapeutic Exercise Program
Suprascapular nerve block with physical therapy

A physical therapy program (5 days a week for 3 weeks, a total of 15 sessions), including a hot pack at 60 ° C for 20 minutes, conventional TENS at 80 Hz for 20 minutes and US at 3 MHz frequency and an intensity of 1.5 watts / cm2, was applied to the relevant shoulder area of all patients. After physical therapy, all the participants received therapeutic exercise program (3 sets of 10 reps with 3- minute intervals between the sets) consisting of active-assisted ROM, passive stretching and Codman exercises for their shoulder joint for 30 minutes in accompany with a physiotherapist.

Also known as: Transcutaneous Electrical Nerve Stimulation (TENS), Hot Pack, Ultrasound(US) Therapy, Therapeutic Exercise Program
Only physical therapy

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Between the ages of 18-65,
  • Having pain lasting longer than 3 months,
  • Full range of joint motion
  • Patients with shoulder pain due to biceps tendinitis, impingement syndrome, rotator cuff diseases (tendinosis, calcific tendonitis, etc.)

You may not qualify if:

  • Inflammatory rheumatic disease (rheumatoid arthritis, ankylosing spondylitis, etc.),
  • Full thickness rotator cuff tear
  • Glenohumeral disorders (arthritis, osteoarthritis, osteonecrosis, glenohumeral instability)
  • Regional disorders (cervical radiculopathy, brachial neuritis, entrapment neuropathies, reflex sympathetic dystrophy, neoplasms, etc.)
  • Diagnosed with metabolic syndrome, diabetes mellitus (DM), hypertension (HT)
  • Having a diagnosed neuro-psychiatric problem,
  • Undergoing malignancy treatment,
  • Having a bleeding disease,
  • Having an infectious disease with fever,
  • Who have undergone surgery on the shoulder,
  • Patients who received physical therapy in the last year

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

UsakU

Merkez, Uşak, 64200, Turkey (Türkiye)

Location

MeSH Terms

Interventions

Physical Therapy ModalitiesTranscutaneous Electric Nerve StimulationTherapeutics

Intervention Hierarchy (Ancestors)

RehabilitationElectric Stimulation TherapyAnalgesiaAnesthesia and Analgesia

Study Officials

  • Kağan Özkuk

    Uşak University

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assoc. Prof.

Study Record Dates

First Submitted

November 3, 2023

First Posted

November 18, 2023

Study Start

February 1, 2020

Primary Completion

May 1, 2020

Study Completion

December 1, 2020

Last Updated

November 18, 2023

Record last verified: 2023-11

Data Sharing

IPD Sharing
Will not share

Locations